Molecular Microbiology (2010) 77(3), 658â€“671 äŠ?                                                           doi:10.1111/j.1365-2958.2010.07236.x
                                                                                                          published online 15 June 2010



Trypanosoma brucei pteridine reductase 1 essential survival vitro virulence mice                                          mmi_7236 658..671




Natasha Sienkiewicz, Han B. Ong                                aromatic amino acid hydroxylases, glyceryl ether
Alan H. Fairlamb*                                                  monooxygenases synthases (Thony et al., 2000;
Division Biological Chemistry & Drug Discovery,                 Werner-Felmayer et al., 2002; Schmidt Alp, 2007;
College Life Sciences, University Dundee,                    Watschinger et al., 2009). humans, H4B synthe-
Dundee, UK.                                                        sized novo GTP salvaged dihydrobiop-
                                                                   terin (H2B) NADPH-dependent dihydrofolate
                                                                   reductase (DHFR, EC 1.5.13) (Nichol et al., 1983) Summary                                                            regenerated quinonoid dihydrobiopterin, 
Gene knockout knockdown methods used                   product hydroxylation reactions, NAD(P)H-
examine essentiality pteridine reductase (PTR1)              dependent 6,7-dihydropteridine reductase (DHPR; EC
pterin metabolism African trypanosome.                      1.5.1.34) (Armarego et al., 1983).
Attempts generate PTR1 null mutants blood-                      contrast humans, biological genomic data
stream form Trypanosoma brucei proved unsuccess-                   indicate trypanosomatids lack ability synthesize
ful; despite integration drug selectable markers             pterins novo, totally dependent salvage target locus, gene PTR1 retained            extracellular pterins growth (Bello et al., 1994; Cun- locus genome.                      ningham Beverley, 2001; Berriman et al., 2005; Ivens  RNA interference (RNAi) resulted com-                  et al., 2005). essential requirement pterins plete knockdown endogenous protein 48 h,                  initially discovered Crithidia fasciculata grown followed cell death 4 days. lethal pheno-            defined medium containing low amounts folate (Kidder
type reversed expression enzymatically                   Dutta, 1958; Kaufman, 1963); subsequent
active Leishmania major PTR1 RNAi lines (oeRNAi)                understanding uptake, salvage functions addition tetrahydrobiopterin cultures. Loss            pterins trypanosomatids come principally PTR1 associated gross morphological                    studies Beverley Ouellette groups (Nare et al.,
changes defect cytokinesis, resulting               1997; Ouellette et al., 2002). Leishmania spp., biopterin
cells multiple nuclei kinetoplasts,            taken medium biopterin transporter
multiple detached flagella. Electron microscopy               BT1 (Kundig et al., 1999; Lemley et al., 1999) revealed increased numbers glycosomes,                    sequentially reduced H2B H4B pteridine reduc-
immunofluorescence microscopy showed increased                     tase 1 (PTR1; EC 1.5.1.33) (Bello et al., 1994). Previous diffuse staining glycosomal matrix                    studies Leishmania ptr1 - mutants suggested pres-
enzymes, indicative mis-localisation cytosol.            ence residual pteridine reductase activity, provision-
Mis-localisation confirmed digitonin fraction-              ally assigned PTR2. activity considered ation experiments. RNAi cell lines markedly              quinonoid dihydropteridine reductase virulent wild-type parasites mice virulence            identity PTR2 remains unknown (Lye et al., 2002). restored oeRNAi line.  PTR1               kinetic, inhibitor structural properties drug target human African trypanosomiasis.                     reported PTR1 Leishmania major (Luba
                                                                   et al., 1998; Gourley et al., 2001; Schuttelkopf et al.,
                                                                   2005), Trypanosoma cruzi (Schormann et al., 2005) Introduction                                                       Trypanosoma brucei (Dawson et al., 2006; Mpamhanga
                                                                   et al., 2009; Shanks et al., 2010). Gene knockout studies
Tetrahydrobiopterin (H4B) essential cofactor                                                                    L. major demonstrated PTR1 essential various hydroxylation reactions catalysed enzymes
                                                                   growth insect promastigote stage parasite,
Accepted 20  2010.  correspondence. E-mail h.fairlamb@   growth ptr1 - null mutants restored dundee.ac.uk; Tel. (+44) 1382 385155; Fax (+44) 1382 385542.       H2B H4B, dihydro- tetrahydrofolate (Bello use article permitted accordance Terms Conditions set http://www3.interscience.wiley.com/      et al., 1994). mutants showed increased formation
authorresources/onlineopen.html                                    mammalian-infective metacyclic promastigote forms Â© 2010 Blackwell Publishing                                                                                                    Essentiality pteridine reductase 1 659

stationary phase cultures consequently gave larger             drug selection hygromycin puromycin,
lesions injected mice (Cunningham et al.,                essentially described (Sienkiewicz et al., 2008). SKO
2001). indicates ptr1 - amastigotes viable        lines (PTR1/ptr1::HYG [SKOHYG] PTR1/ptr1::PAC
vivo, presumably abundant H4B host macroph-              [SKOPAC]) subjected second round trans-
ages consequently PTR1 drug target            fection knockout construct selected L. major.                                               resistance drugs. Despite obtaining double drug-
   PTR1 secondary role metabolism able           resistant trypanosomes numerous independent experi- reduce dihydrofolate tetrahydrofolate. Amplification         ments, unable obtain clones PTR1 Leishmania spp. mecha-            copies PTR1 deleted. Southern blotting 
nisms parasites acquire resistance antifolates         firmed integration drug-resistant genes methotrexate (Callahan Beverley, 1992;                 occurred correct locus, associated
Papadopoulou et al., 1992; Bello et al., 1994)           retention additional copy PTR1 acting pass mechanism sequestering             locus genome  Fig. S1). DHFR inhibitors. Recent studies demonstrated               virulent strains leishmania, behaviour typical intriguing link unconjugated pterins oxidative         essential gene (Cruz et al., 1993), susceptibility variety Leishmania PTR1 knockout            reported African trypanosome.  overexpressing cell lines (Moreira et al., 2009; Nare          increase chromosomal copy number reported
et al., 2009).  mechanism involved              trypanosomes selected resistance mycophenolic
clear; known pterins additional         acid, inhibitor IMP dehydrogenase (Wilson et al.,
essential functions parasites.                            1994). Attempts generate conditional double knockout
   contrast Leishmania spp. virtually known       cell lines introducing ectopic copy PTR1 pterin metabolism African trypanosomes, para-             (pLew100_TbPTR1) tetracycline control sites occupy completely different (extracellular) envi-     unsuccessful.
ronment mammalian host. study use                   light results, inducible RNA interference
genetic methods examine role PTR1 blood               (RNAi) studies using p2T7TiTAblue stream form T. brucei respect essentiality vitro        undertaken deplete cells PTR1 (Alibu et al., 2005). infectivity vivo. findings suggest reduced         disruption PTR1 function, 403 bp region pterins required glycosome flagellar biogenesis        ligated p2T7TiTAblue vector linearized  loss PTR1 activity compensated           struct transfected WT cells electroporation. Cells reduced pterins plasma extracellular fluids.        integrated construct rDNA loci unlike L. major, PTR1 potential drug target            homologous recombination obtained selection
African trypanosome reference DHFR.                     hygromycin cloned. Generation                                                                    correct RNAi clones confirmed Southern analysis
                                                                   (data shown), tetracycline added cell
Results                                                            cultures initiate expression PTR1-specific
                                                                   double-stranded RNA. average cumulative growth
Genotypic phenotypic analysis TbPTR1
                                                                   different freshly derived clones illustrated knockdown parasites
                                                                   Fig. 1A. absence inducer cells grew assess essentiality PTR1, classical gene                 essentially rate WT cells.  following
replacement methods undertaken try produce            induction PTR1 dsRNA, growth ceased 1 day,
PTR1 null cell line bloodstream trypanosomes. Consis-           followed decline cell numbers motile
tent genome sequence data strain 927 (Berriman            parasites visible 4 days. Levels PTR1 protein
et al., 2005), Southern blot analysis confirmed PTR1          diminished compared WT non-induced RNAi single copy haploid genome â€˜single markerâ€™           lines (Fig. 1A, inset) compared immunoglobulin
bloodstream T. brucei 427 used studies (data          heavy-chain-binding protein (BiP) used loading
shown). organism, subsequently referred wild-           control. Densitometry PTR1 band relative BiP
type (WT), constitutively expresses T7 RNA polymerase              control band indicated non-induced RNAi line tetracycline repressor protein, used         50  WT protein levels; decreased 9 
express RNA constructs control tetra-           24 h RNAi induction detectable
cycline (Wirtz et al., 1999). Replacement copy           48 h. RNAi phenotype unstable; PTR1 generate single knockout (SKO)                  tetracycline-induction repeated 2â€“3
readily achieved transfection construct contain-         weeks culture, cells showed growth defect
ing drug resistance gene  HYG PAC) flanked             knockdown PTR1, brief cytostasis followed 5â€²- 3â€²-untranslated regions PTR1, followed           normal growth (Fig. S2). confirm cidal effect

Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 660 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?




Fig. 1. effect RNAi-dependent depletion PTR1 growth presence absence tetrahydrobiopterin.  Effect RNAi cell growth. independent RNAi clones analysed growth defects following induction tetracycline absence tetrahydrobiopterin. WT (open circles) RNAi cells (non-induced cells â€“ open squares induced cells â€“ closed squares) seeded 1 Â¥ 104 cells ml-1 growth determined 2 week period. WT, non-induced induced cells (1 Â¥ 106 cells lane) harvested 0 (non-induced), 24 h 48 h (induced) processed Western blot analysis. blot sequentially probed anti-TbPTR1 (inset, lower panel) anti-TbBIP (inset, upper panel) loading control.
B. Effect tetrahydrobiopterin cell growth. WT cells freshly derived RNAi clone seeded FDM HMI9-T supplemented 10 mM tetrahydrobiopterin 1 Â¥ 104 cells ml-1 growth monitored 1 week. Symbols: WT (open circle; additions),
non-induced RNAi cells (closed circles) tetracycline-induced cells plus minus tetrahydrobiopterin (closed open squares
respectively). Data shown FDM  HMI9-T shows essentially effect.

 RNAi loss PTR1 activity, effect                  identity.  LmPTR1 mRNA suscep-
supplementation H4B examined freshly                       tible degradation, assembly RNA-induced
derived clone (Fig. 1B). Addition 10 mM H4B RNAi-                  silencing complex requires formation 20â€“26-mer
induced cultures abolished lethal growth phenotype.                  double-stranded RNA (Ullu et al., 2004).  following
   Additional evidence essential requirement                  tetracycline induction, oeRNAi cells showed sign PTR1 activity obtained introducing inducible                   growth defect whatsoever (Fig. 2A). Western blotting overexpressing ectopic copy L. major PTR1                    antisera raised recombinant T. brucei PTR1
WT line (oeWT) prior generation TbPTR1 RNAi lines                  showed TbPTR1 expression undetectable follow-
(oeRNAi). high GC content L. major gene,               ing induction (Fig. 2B; TbPTR1 ~30 kDa 55 kDa sequence identity T. brucei RNAi construct               cross-reacting band serves internal loading control). 50 , 13 nucleotide stretches                 contrast, Western blotting second antiserum

                                                                                              Fig. 2. Rescue RNAi growth defect                                                                                               expression LmPTR1.
                                                                                               Cumulative growth WT (open circles)
                                                                                              non-induced oeRNAi cells (open inverted
                                                                                              triangles) tetracycline-induced oeRNAi
                                                                                              cells (closed triangles).
                                                                                              B. Western blot analysis demonstrating
                                                                                              knockdown TbPTR1 oeRNAi cells.
                                                                                              Non-induced (-) 48 h tetracycline induced
                                                                                              (+) cells probed sequentially                                                                                               anti-TbPTR1 anti-LmPTR1. 55 kDa
                                                                                              non-specific band detected                                                                                               anti-TbPTR1, effect                                                                                               knockdown PTR1 serves internal
                                                                                              loading control  panel), LmPTR1                                                                                               present  panel).




                                                                  Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
                                                                                                          Essentiality pteridine reductase 1 661

                                                                     initial lag growth compared WT (Fig. 1B).                                                                      10 mice treated doxycycline failed develop para-
                                                                     sitaemia survived 30 days. Infection                                                                      oe
                                                                       RNAi cells  doxycycline) restored                                                                      virulence phenotype WT cells.


                                                                     Morphological changes associated PTR1 depletion

                                                                     Severe morphological abnormalities observed                                                                      bloodstream trypanosomes light electron micros-
                                                                     copy prior cell death. induction RNAi                                                                      24â€“48 h, cells showed reduced motility, fatten-
                                                                     ing cell body shortening flagellum com-
                                                                     pared control (non-induced) samples. 72 h,
                                                                     Giemsa-stained preparations showed gross distension                                                                      cell body multiple nuclei, kinetoplasts Fig. 3. PTR1 enzyme activity WT transgenic T. brucei.         flagella.
Cell lysates assayed PTR1 activity various protein          provide insight changes cell cycle
concentrations described materials methods. WT,        progression, DAPI-stained cells analysed deter-
open circles; SKO, closed circles; oeRNAi minus tetracycline, open
squares; oeRNAi plus tetracycline, closed squares.                   proportion cells nucleus (N)
                                                                     kinetoplast (K) control, non-induced                                                                      tetracycline induced populations (Fig. 5). Non-induced
specific L. major PTR1 shows opposite effect.                 samples predominately 1K1N (92 ), tetra-
LmPTR1 visible ~30 kDa band non-induced                   cycline induction caused dramatic time-dependent
 leaky nature promoter pLew82) increases following induction. PTR1 activity mea-
sured cell lysates validate results. shown Fig. 3, PTR1 activity proportional protein concentra-
tion cell line. WT cells specific activity 22.9 â«¾ 1.9 nmol min mg-1 decreased 8.0 â«¾ 0.2 nmol min mg-1 SKO line, increases 2.5- 10-fold RNA lines overexpressing
LmPTR1 absence presence inducer
(58.1 â«¾ 9.3 231 â«¾ 19 nmol min mg-1 respectively). results demonstrate LmPTR1 enzymatically
active expressed T. brucei able rescue lethal RNAi phenotype.
   Infectivity studies undertaken mice examine virulence RNAi oeRNAi transgenic
trypanosomes. Wild-type non-induced transgenic
cells inoculated paired groups mice, pair received doxycycline drinking water.
Parasitaemia monitored intervals 30 days;
animals achieving parasitaemia greater 108 trypa-
nosomes millilitre euthanized previous
studies established levels consis-
tently lethal 24 h. Mice infected 105
WT cells unable survive longer 3â€“4 days                 Fig. 4. Virulence phenotype PTR1 mutants mice. Groups (Fig. 4), mice infected RNAi cells survived             mice infected WT, non-induced cells RNAi                                                                      oe
                                                                       RNAi cells parasitaemia monitored intervals 30 day longer regardless doxycycline treatment.             period. Kaplan-Meier survival graph shows aggregated
reduced virulence observed minus doxycycline                  results independent experiments. Symbols: WT infection, group probably leaky transcription p2T7            doxycycline (black dashed line); RNAi infection, doxycycline
                                                                     (blue solid line); RNAi infection plus doxycycline (red solid line);
promoter, lowers baseline expression PTR1               oe
                                                                       RNAi infection, doxycycline (red dashed line); oeRNAi infection
(Fig. 1A) instances associated                doxycycline (black dashed line, identical WT infection).

Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 662 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?

                                                                                       Fig. 5. PTR1 depletion results changes                                                                                        cell cycle progression. Microscopic analysis                                                                                        DAPI stained RNAi cells non-induced (0 h)
                                                                                       induced (24, 48 72 h) populations
                                                                                       analysed determine proportion                                                                                        trypanosomes different numbers                                                                                        kinetoplasts (K) nuclei (N). Percentage
                                                                                       bar chart depicts changes K/N content
                                                                                       cell tetracycline induction RNAi.
                                                                                       Approximately 300 parasites population
                                                                                       analysed (n = 2, â«¾ SD): non-induced
                                                                                       control (black bars); 24 h induction (dark grey
                                                                                       bars); 48 h induction (light grey bars)                                                                                        72 h induction (white bars).




decrease number 1K1N trypanosomes (28                  ing membrane (Fig. 6D, arrowheads). Multiple entangled
72 h) corresponding increase cells containing             flagella clearly identified SEM DAPI- multiple kinetoplasts plus multiple nuclei (MKMN)         stained image (Fig. 6E F respectively). Phase-
anucleated zoids (1K0N). number cells               contrast light microscopy wet preparations showed kinetoplasts nucleus (2K1N) increased threefold             grossly abnormal parasites viable, mul- 6  19  48 h induction, decreasing 8             tiple flagella moving uncoordinated fashion 72 h. 2K2N did vary markedly                  detached flagella instances radiating time course. results suggest cells              central body directions. consider-
undergo rounds mitosis, cytokinesis.             able disruption parasite surface appears
   Ultra-structural surface alterations examined           membrane disorganization deterioration. transmission electron microscopy (TEM) scanning              changes highlighted surface probably indi-
electron microscopy (SEM) (Fig. 6). obvious                cation stages RNAi effect cells aberrant feature present TEM sections RNAi-           close death, seen central parasite
induced cells increased number membrane                   Fig. 6D.
bound electron-dense bodies (Fig. 6B C) compared                   identity electron-dense organelles gly- non-induced control (Fig. 6A). round,                cosomes verified immuno-cytochemistry. TEM sausage-shaped (Fig. 6C, inset) bodies                sections WT, non-induced induced samples morphologically similar glycosomes, organelle                 72 h labelled antibody glycosomal
related peroxisomes (Opperdoes et al., 1984).            matrix enzyme marker, T. brucei glyceraldehyde phos-
distinct feature treated cells increased            phate dehydrogenase (GAPDH) visualized number flagella present 72 h sections                     10 nm protein gold particles (Fig. 7). non-
(Fig. 6Bâ€“E, arrowheads). aber-             induced samples, gold particles exclusively localized
rant number flagella associated main body            glycosomes confirming specificity antibody parasite, appear normal 9 + 2                  reagent (Fig. 7A B). contrast, induced
arrangement microtubules axoneme                  samples pronounced labelling glycosomes paraflagellar rod, suggesting structural organisa-         additional gold particles cytosol (Fig. 7C D,
tion flagellum unaffected PTR1 depletion.              arrows). matrix elongated electron-dense sections appear flagel-             structure Fig. 7D heavily stained confirming
lar pocket (Fig. 6B), number autophagic             sausage-shaped structures (Fig. 6C) likely
vacuoles. Lastly, structures evident sec-              glycosomes.
tions, appeared internal non-membrane                   verify increase number bound flagellum (Fig. 6B plus inset, starred), phenotype          glycosomes following PTR1 depletion, immunofluores-
previously observed knockdown VSG (Sheader                cence studies undertaken using anti-GAPDH. Stain-
et al., 2005). Compared normal trypanosome                   ing GAPDH non-induced control punctate (Fig. 6D, inset), tetracycline-induced trypanosomes            nature (Fig. 8A), pronounced diffuse increase body size having sections               following induction tetracycline 48 h. Staining
flagella detached body lacking undulat-            increased level covered entire

                                                              Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
                                                                                                             Essentiality pteridine reductase 1 663




Fig. 6. Morphology PTR1-depleted cells electron microscopy.  TEM section non-induced controls.
B C. TEM sections 72-h induced cells depicting increased number flagella glycosomes.
D. SEM images 72-h induced cells, normal  left) abnormal  right) appearance compared non-induced
control (inset).
E. Equivalent DAPI-stained 72-h induced cell multiple flagella.
Abbreviations used TEM sections: nucleus (N); nuclear membrane (NM); basal bodies (BB); kinetoplast (K); flagellar rod (FR); flagellar
pocket (FP); axonemes (Ax black arrow heads); glycosomes (G); lysosomes (L); paraxial rod (PR); microtubules (MT); acidocalcisomes
(Ac); autophagic vacuoles (AV) internal non-membrane bound flagellum (*). White arrow heads SEM images highlight flagella. Black white bars represent 200 nm.



body parasite 72 h. punctate staining                  48 h resulted partial diffuse staining cyto- visible long structures radiating                plasm;  unlike GAPDH, punctuate staining main body multinucleated multiki-                  visible flagella 72 h.
netoplast parasites (Fig. 8C). structures 
firmed detached flagella staining antibody                                                                          Subcellular distribution PTR1 glycosomal markers paraflagellar rod protein, ROD1 (Fig. 9). increase glycosomal staining pattern illustrated GAPDH fol-               Cytosolic glycosomal fractions bloodstream form T.
lowing RNAi expression confirmed using alterna-                   brucei prepared ultracentrifugation, following digi-
tive glycosomal matrix marker, aldolase (ALD). Induction                 tonin treatment WT 48 h induced RNAi cells 
Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 664 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?




Fig. 7. Localization distribution GAPDH immuno-gold labelling. layer sections labelled anti-GAPDH stained protein gold particles examined TEM. WT  , RNAi non-induced (B) induced (Câ€“D) 72 h. Abbreviations used: nucleus (N);
glycosome (G) white asterisks alongside black dots represent 10 nm gold particles present glycosomes, white arrows depict
particles outside glycosomes. Scale bar represents 200 nm.




Fig. 8. effect PTR1 depletion subcellular distribution glycosomal matrix enzyme, GAPDH immunofluorescence
microscopy. Non-induced  , induced 48 h (B) 72 h (C) RNAi cells labelled glycosomal matrix marker, GAPDH (green) staining nuclear kinetoplast DNA DAPI (blue). MN, multinucleated, MK, multikinetoplastid. Scale bar represents 10 mm.

                                                                  Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
                                                                                                              Essentiality pteridine reductase 1 665




Fig. 9. Immunolocalisation aldolase paraflagellar rod marker, ROD1 RNAi depleted cells. localization aldolase (glycosomal
marker, green) ROD1 (paraflagellar rod marker, red) DAPI (blue) RNAi cells. Non-induced  ; induced 48 h (B); 72 h (C)
RNAi cells. MN, multinucleated, MK, multikinetoplastid, scale bar represents 10 mm.


analysed Western blotting antibodies specific                 samples possible lack material, cytosolic glycosomal markers (Fig. 10). PTR1                     increased GAPDH observed 48 h induc-
recovered exclusively cytosolic fraction               tion, supports mis-localization GAPDH cytosolic enzyme marker, enolase. Similar results                    cytosol illustrated immuno-gold labelling studies obtained procyclic forms (Fig. S3). Reduced                     72 h (Fig. 7).
levels PTR1 evident cytosolic non-induced
fraction RNAi cells compared WT, leaky                Discussion
nature p2T7TiTAblue RNAi vector (Alibu et al., 2005).
                                                                         gene knockout, RNAi knockdown rescue studies
Following RNAi induction 48 h, PTR1 limit
                                                                         reported provide strong evidence PTR1 detection, enolase PEX13, glycosomal
                                                                         essential blood-stream form African
membrane-bound protein, unchanged. Densitom-
                                                                         trypanosome. Loss PTR1 RNAi cytocidal etry band stained glycosomal matrix enzyme
                                                                         cytostatic, distinct advantage drug
GAPDH indicated pellet fraction unchanged
                                                                         discovery perspective. lethal RNAi phenotype cytosol increased approxi-
                                                                         rescued expression functionally active L. major
mately twofold. analysis 72 h induced
                                                                         PTR1, supplementation tetrahydrobiopterin.
                                                                         PTR1 levels markedly reduced absence
                                                                         inducer poor regulation pLew82 vector.
                                                                         discernable effect growth rich
                                                                         medium vitro, virulence PTR1 RNAi T. brucei
                                                                         considerably attenuated mice. loss viru-
                                                                         lence evident RNAi induced,                                                                          mice succumbed infection. likely                                                                          instability RNAi machinery previously
                                                                         reported (Chen et al., 2003).  supplemen-
                                                                         tation 10 mM tetrahydrobiopterin able rescue
                                                                         trypanocidal effect vitro, definitively
                                                                         exclude possibility steady-state levels tet-
                                                                         rahydrobiopterin present animal host plasma
Fig. 10. effect PTR1 depletion subcellular                 (~0.1 mM) contributing survival (Fukushima distribution glycolytic enzymes. Digitonin fractionation intact
WT RNAi cells grown 48 h  absence â€˜â€“â€™ presence        Nixon, 1980; Yoshida et al., 2000). fact BH4 â€˜+â€™ tetracycline) incubated 150 mg ml-1 digitonin    extremely unstable culture medium repeated
processed described Material Methods. release           daily addition BH4 toxic T. brucei
PTR1, enolase, PEX13 GAPDH digitonin-treated cells determined supernatant (S) pellet (P) fractions            explain failure generate double knockout
Western blot.                                                            line using BH4 nutritional rescue.  ultimate proof

Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 666 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?
 PTR1 suitable drug target requires               resulted smaller numbers larger glycosomes (Baner-
chemical validation using potent specific drug-like               jee et al., 2005).  studies reported
inhibitors PTR1 appropriate pharmacological                   defects cytokinesis observed 
properties. Unfortunately, currently available inhibitors            discovery TbPTR1 present meet specifications (Cavazzuti et al., 2008;             cytosol bloodstream (Fig. 10) procyclic forms
Mpamhanga et al., 2009; Shanks et al., 2010). Nonethe-                (Fig. S3) refutes predicted glycosomal location  combined inhibition dihydrofolate reductase              PTR1, based PST1 consensus sequence -VHA PTR1 remains attractive chemotherapeutic strategy                  C-terminus (Opperdoes Szikora, 2006). (Hardy et al., 1997; Cavazzuti et al., 2008; Tulloch et al.,          consistent failure detect PTR1 proteomic
2010).                                                                analysis purified T. brucei glycosomes (Vertommen
   morphological data illustrate knockdown                et al., 2008) agrees cytosolic location PTR1 results cells unable divide normally,             GFP-PTR1 chimera L. donovani (Kumar et al., 2007). undergo nuclear division kine-            Likewise, trypanothione reductase trypan-
toplast segregation. Formation multiflagellated para-              othione peroxidase T. brucei contain putative
sites reported number RNAi                glycosomal targeting sequences, clearly
studies dissecting organelle biogenesis including: deple-             cytosolic (Smith et al., 1991) located tion trypanin, component dynein regulatory                cytosol mitochondria (Schlecker et al., 2005).
complex flagellum (Ralston Hill, 2006); deple-             underlines need experimental verification tion centrin1, component associated basal               silico bioinformatic predictions (Wanders bodies responsible segregation linked                  Waterham, 2006).
organelles: flagellum, kinetoplasts Golgi (Selva-                    PTR1 clearly pleiotropic effects cytokinesis,
pandiyan et al., 2007); depletion aurora-like kinase           flagellar morphology glycosome biogenesis. AUK1, chromosome passenger protein (Li Wang,                    challenging question underlying biochemical
2006; Jetton et al., 2009); depletion CAP5.5 result-           mechanism? known functions PTR1, ing defects microtubule organization (Olego-                    maintenance biopterin tetrahydro-form Fernandez et al., 2009).  studies               likely salvage folate dihydrofolate, observed glycosomal abnormalities reported                   growth phenotype rescued supple-  work required determine             mentation H4B high- low-folate media containing
RNAi mutants cytokinesis defects similar              thymidine. functions pterins remain glycosomal abnormalities.                                             elucidated T. brucei speculate    Knockdown PTR1 affects glycosomal numbers                  functions  example, ether lipid morphology, judged TEM. PTR1 knock-                   biosynthetic pathway present mammalian peroxi- causes partial mislocalisation cytosol            somes cells (Kaufman et al., 1990) trypanosomatid glycosomal matrix enzymes, GAPDH aldolase,                 glycosomes (Lux et al., 2000; Parsons et al., 2001;
seen immunofluorescence digitonin fraction-                Michels et al., 2006). date, enzymes ation experiments. view, mislocalization              pathway identified trypanosomatids defective import glycosome           fractionation, bioinformatic proteomic based analysis
loss integrity glycosomal membrane.                 (Heise Opperdoes, 1997; Opperdoes Szikora,
similar effects observed studies functional roles           2006; Vertommen et al., 2008), peroxins attributed defective import.             known pterin-dependent.  BH4 involved
oxins (PEX) large family peroxisomal proteins                ether lipid catabolism mammalian cells, involved glycosomal biogenesis                   serves essential cofactor cleavage ether
import newly synthesized proteins cytosol                 lipids glyceryl ether monooxygenase (EC 1.14.16.5)
(Parsons et al., 2001). Cellular knockdown RNA inter-              located microsomal compartment (Watschinger
ference PEX 13 (Furuya et al., 2002; Verplaetse et al.,            et al., 2009). ultimate products ether lipid cleavage
2009), GIM5  PEX11-related protein) (Furuya et al.,                 glycerol fatty alcohol. Possibly, fatty alco-
2002; Moyersoen et al., 2003; Voncken et al., 2003; Ver-              hols serve subsequent ether lipid synthesis plaetse et al., 2009), PEX14 (Moyersoen et al., 2003),                glycosome.  fact oxidative cleavage
PEX19 (Banerjee et al., 2005); PEX6, PEX10                    ether lipids L. donovani dependent
PEX12 (Krazy Michels, 2006) resulted                   NADPH tetrahydrobiopterin (Ma et al.,
partial mislocalization glycosomal matrix enzymes               1996) tends argue hypothesis. Tetrahydro- cytosol. Overexpression PEX11 led increased              biopterin plays role defence oxidative
number glycosomes elongated clus-                   nitrosative stress mammalian cells (Mogi et al.,
tered (Lorenz et al., 1998), knockdown PEX19               1999; Ozkor Quyyumi, 2008) recent studies 
                                                                Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
                                                                                                      Essentiality pteridine reductase 1 667

PTR1 knockout overexpressing lines suggest                   Western blot analysis
similar role Leishmania spp. (Moreira et al., 2009; Nare
                                                                   WT, RNAi (0, 24 48 h) oeRNAi (48 h) cells et al., 2009).
                                                                   centrifuged 20 000 g 5 min 4Â°C. cell pellets
   conclusion, data strongly suggest PTR1           (1 Â¥ 106 parasites sample) resuspended SDS
essential blood stream T. brucei growth sur-           Laemmli buffer, boiled 5 min micro-centrifuged vival vitro animal host. phenotypic abnor-        supernatants separated SDS-
malities uncovered investigation suggest                 PAGE subsequently transferred nitrocellulose potential role PTR1 biogenesis glycosome         immunoblotting previously described (Sienkiewicz et al., flagellum. studies underway             2008). immunoblot RNAi set sequentially
                                                                   probed polyclonal antisera raised T. brucei
laboratory investigate possibilities.
                                                                   PTR1 (1:500 dilution) BiP (1:10 000), conjunction                                                                    secondary rabbit anti-rat HRP-conjugated antibody
                                                                   (1:5 000, Dako). oeRNAi samples sequentially
Experimental procedures                                            probed T. brucei PTR1 antisera L. major PTR1
                                                                   (1:10 000), conjunction secondary rabbit anti-rat Trypanosome culture
                                                                   goat anti-rabbit HRP-conjugated antibodies (1:5000 Trypanosoma brucei bloodstream form â€˜single markerâ€™ S427           1:10 000 respectively) immunoblots visualized (T7RPOL TETR NEO) transfected cells cultured           ECL plus (enhanced chemiluminescence) previously described (Wirtz et al., 1999) (Alibu et al.,       GE Healthcare.
2005). Folate deficient media (FDM) growth conditions
used study previously described (Sienkiewicz
et al., 2008). Tetrahydrobiopterin purchased B.           Enzyme assays
Shircks Laboratories (Jona, Switzerland) 10 mM stock           Lysates T. brucei prepared previously described prepared degassed 0.1 M HCl.
                                                                   (Vickers Fairlamb, 2004). ensure adequate extraction
                                                                   parasites, trypanothione reductase activity measured
                                                                   clarified lysates previously described (Jockers-Scherubl
Cloning generation transgenic cell lines                    et al., 1989). Assays PTR1 activity clarified lysates constructs sequenced prepared elec-          carried 22Â°C 50 mM HEPES (pH 7.4), containing
troporation using QIAprep Miniprep Plasmid Kit (Qiagen).           0.1  (v/v) triton X-100, adjusted ionic strength DNA constructs prepared electroporation trypa-       100 mM KCl. Lysates preincubated 100 mM
nosomes cloned procedures performed pre-           NADPH cofactor 2 min reactions initiated viously described (Wirtz et al., 1999; Sienkiewicz et al.,         addition 25 nM H2B, final volume 200 ml. Enzymatic
2008). Primers used study generate RNAi         reactions incubated 1 min, aliquots
overexpressor constructs (Table S1) based               (100 ml) removed oxidized iodine alka-
GeneDB sequences T. brucei PTR1 (Tb927.8.2210, 927             line conditions analysed HPLC previously
strain) L. major PTR1 (LmjF23.0270, Friedlin strain).      described (Shanks et al., 2010). Protein measured using disruption PTR1 function, 403 bp region (nucleotide       Coomassie blue using bovine serum albumin standard
position 399â€“801; http://trypanofan.path.cam.ac.uk/software/       (Bradford, 1976).
RNAit.html) directly ligated p2T7TiTAblue vector
(http://trypanofan.path.cam.ac.uk/trypanofan/vector/; gen-
                                                                   Morphological analysis
erous gift David Horn), linearized digestion NotI transfected electroporation generate RNAi cells          RNAi cells (grown presence absence tetracy- hygromycin selection (4 mg ml-1). overexpressor           cline) fixed methanol 4  (v/v) paraformaldehyde
construct (pLew82), containing L. major PTR1 ORF           stained Giemsa 4â€²,6-diamidino-2- generation overexpressor WT (oeWT)             phenylindole (Slowfade Gold antifade reagent DAPI, phleomycin selection (2.5 mg ml-1). oeWT cells gen-      Invitrogen). Images captured Zeiss Axiovert 200 M
erated used reintroduction p2T7TiTAblue        fluorescence light microscope using Zeiss AxioVision
RNAi construct generate oeRNAi cells. tetracycline          Software. Approximately 300 parasites population induction experiments initiated 1 Â¥ 104 cells ml-1     assessed changes N:K ratio data presented tetracycline added daily 1 mg ml-1.                             mean independent knockdown experiments. elec-
                                                                   tron microscopy, cells fixed 24 h 2  (v/v) glutaral-
                                                                   dehyde 4  (v/v) paraformaldehyde 0.2 M PIPES, pH
DNA analysis                                                       7.2 prepared SEM TEM previously
                                                                   described (Sienkiewicz et al., 2008). WT RNAi genomic DNA (5 mg) digested restriction enzyme StuI blots subsequently probed TbPTR1 ORF described previously (Sienkiewicz               Immuno-gold labelling TEM sections
et al., 2008). Southern blot analysis used confirm successful integration selectable gene markers         immunoelectron microscopy labelling staining
WT cells  Supporting information ).                            procedure carried essentially described (Sandi-

Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 668 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?

lands et al., 2004; Sienkiewicz et al., 2008). Briefly, samples           Research Institute (NMRI) mice (5 group) infected
previously embedded Durcupan resin etched 1                  single intraperitoneal injection 105 parasites 0.2 ml
(v/v) periodic acid osmium removed 2  (w/v)                    glucose saline previously described (Sienkiewicz et al.,
sodium periodate. sections probed anti-                2008). RNAi oeRNAi cells, single inoculum GAPDH (1: 50 dilution) antibody subsequently incubated                non-induced cells infected sets mice Protein labelled 10 nm gold particles (1:50 dilu-             group given 2.5 mg ml-1 doxycycline drinking
tion, BB International) visualize primary antibody.            water (starting week prior infection continuing
sections stained 3  (v/v) aqueous uranyl acetate                30 day period). Animals fed ad libitum Reynoldâ€™s lead citrate prior examination JEOl-              standard chow (Diet 3, SAS, Edinburgh). Parasitaemia levels
1200 EX TEM.                                                              monitored 30 day experiment (Sienk-
                                                                          iewicz et al., 2008). animal experiments undertaken                                                                           carried following local ethical review UK regu-
Immunofluorescence                                                        latory licensing accordance European Communi-
                                                                          ties Council Directive (86/609/EEC).
Cells fixed 4  (v/v) paraformaldehyde poly-
L-lysine coated chamber slides probed antisera
raised T. brucei GAPDH (rabbit antiserum, 1:2500),                Acknowledgements
ALD (rabbit antiserum, 1:6000) ROD1 (monoclonal anti-
serum, neat), generous gifts Paul Michels Keith                  like thank Professor Steve Beverley (Washing-
Gull, previously described (Woods et al., 1989; Verplaetse             ton University School Medicine) Professor Paul
et al., 2009). Combination secondary Alexafluor 488                Michels (UniversitÃ© Catholique Louvain), helpful dis-
555 conjugated ant-rabbit anti-mouse immunoglobulins                   cussions, useful advice encouragement; Professor used  1:800 dilution, Molecular Probes) slides              George Cross Dr Simone Leal (Rockefeller University, counter-stained DAPI prior analysis. Images                  New York, USA) provision transgenic cell lines; captured using FITC, Texas Red DAPI filters                   Professor David Horn (London School Hygiene Tropi-
previously described. Property parameters set                 cal Medicine) p2T7TiTAblue vector; Professor Steve
AxioVision microscope software optimize intensity               Beverley, Professor James Bangs (University Wisconsin), fluorescent stains standardized non-induced               Professor Paul Michels Professor Keith Gull (University
controls values retained images                    Oxford) kind gifts antisera helpful insights
captured. Images shown representative indepen-               trypanosome biology; Dr Lucia GÃ¼ther helpful
dent experiments.                                                         discussions reagents; Dr Susan Wyllie critical analy-
                                                                          sis manuscript; Mr Martin Keirens CHIPs
                                                                          facility help advice electron microscopy. Separation cytosolic glycosomal rich proteins                   study supported funding Wellcome Trust
digitonin permeabilization                                                (WT079838 WT WT083481).

Digitonin permeabilization experiments undertaken separate cytosolic glycosomal rich proteins WT               References
RNAi cells (grown absence presence tetracy-
cline 48 h), previously described (Voncken et al.,                 Alibu, V.P., Storm, L., Haile, S., Clayton, C., Horn, D.
2003). Briefly, live cells washed STEN (250 mM                  (2005) doubly inducible RNA interference sucrose, 25 mM Tri-HCl, 1 mM EDTA, 150 mM NaCl, pH 7.4),                     rapid RNAi plasmid construction Trypanosoma brucei.
pelleted resuspended STEN containing 150 mg ml-1                      Mol Biochem Parasitol 139: 75â€“82.
digitonin  final concentration 5 Â¥ 108 cells ml-1)         Armarego, W.L.F., Randles, D., Taguchi, H. (1983) Km
subsequently incubated 1 h ice. digitonin treated                kcat values [6,6,7,7-2H]7,8(6H)-dihydropterin cells fractionated centrifugation (2 min,                      2,6-diamino-5-iminopyrimidin-4 dihydropteridine
20 000 g, 4Â°C) resulting enriched cytosolic (s, super-             reductase. Biochem J 211: 357â€“361.
natant) glycosomal (p, pellet) fractions. Approximately               Banerjee, S.K., Kessler, P.S., Saveria, T., Parsons, M.
5 Â¥ 106 fractionated parasites processed Western                   (2005) Identification trypanosomatid PEX19: functional
blot analysis sequentially probed following anti-              characterization reveals impact cell growth glyco-
bodies raised T. brucei PTR1 (1:500), rabbit antisera               size number. Mol Biochem Parasitol 142: 47â€“55.
raised PEX13 (1:20 000), enolase (1:100 000)                  Bello, R., Nare, B., Freedman, D., Hardy, L., Beverley,
GAPDH (1:100 000). Blots subsequently incubated                   S.M. (1994) PTR1: reductase mediating salvage oxi-
secondary anti-rat (1:5000 dilution) anti-rabbit HRP-                   dized pteridines methotrexate resistance proto-
conjugated antiserum (1:15 000) visualized previously                zoan parasite Leishmania major. Proc Natl Acad Sci USA
described.                                                                  91: 11442â€“11446.
                                                                          Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G.,
                                                                            Renauld, H., Bartholomeu, D.C., et al. (2005) Genome vivo studies                                                             African Trypanosome Trypanosoma brucei. Science
                                                                            309: 416â€“422. cell lines (WT, RNAi, oeRNAi) cultured 24 h           Bradford, M.M. (1976) rapid sensitive method absence selectable drugs female National Medical                  quantitation microgram quantities protein utilizing 
                                                                    Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
                                                                                                      Essentiality pteridine reductase 1 669

  principle protein-dye binding. Anal Biochem 72: 248â€“             cruzi: catalytic properties enzyme inhibition
  254.                                                                studies trypanocidal compounds. Eur J Biochem 180:
Callahan, H.L., Beverley, S.M. (1992) member             267â€“272.
  aldoketo reductase family confers methotrexate resistance        Kaufman, S. (1963) structure phenylalanine-
  Leishmania. J Biol Chem 267: 24165â€“24168.                        hydroxylation cofactor. Proc Natl Acad Sci USA 50: 1085â€“
Cavazzuti, , Paglietti, G., Hunter, W.N., Gamarro, F., Piras,       1093.
  S., Loriga, M., et al. (2008) Discovery potent pteridine      Kaufman, S., Pollock, R.J., Summer, G.K., Das, K.,   reductase inhibitors guide antiparasite drug                     Hajra, K. (1990) Dependence alkyl glycol-ether
  development. Proc Natl Acad Sci USA 105: 1448â€“1453.                 monooxygenase activity tetrahydropterins. Biochim
Chen, Y.L., Hung, C.H., Burderer, T., Lee, G.S.M. (2003)          Biophys Acta 1040: 19â€“27.
  Development RNA interference revertants Trypano-           Kidder, G.W., Dutta, B.N. (1958) growth nutrition
  soma brucei cell lines generated double stranded             Crithidia fasciulata. J Gen Microbiol 18: 621â€“638.
  RNA expression construct driven opposing                  Krazy, H., Michels, P M. (2006) Identification char-
  promoters. Mol Biochem Parasitol 126: 275â€“279.                      acterization peroxins â€“ PEX6, PEX10 PEX12
Cruz, K., Titus, R., Beverley, S.M. (1993) Plasticity        â€“ involved glycosome biogenesis Trypanosoma
  chromosome number testing essential genes                 brucei. Biochim Biophys Acta 1763: 6â€“17.
  Leishmania targeting. Proc Natl Acad Sci USA 90:              Kumar, P., Sundar, S., Singh, N. (2007) Degradation   1599â€“1603.                                                          pteridine reductase 1 (PTR1) enzyme growth phase
Cunningham, M.L., Beverley, S.M. (2001) Pteridine                 protozoan parasite Leishmania donovani. Exp Para-
  salvage Leishmania infectious cycle: impli-          sitol 116: 182â€“189.
  cations antifolate chemotherapy. Mol Biochem Parasitol       Kundig, C., Haimeur, , Legare, D., Papadopoulou, B.,   113: 199â€“213.                                                       Ouellette, M. (1999) Increased transport pteridines com-
Cunningham, M.L., Titus, R.G., Turco, S.J., Beverley,             pensates mutations high affinity folate transporter
  S.M. (2001) Regulation differentiation infective          contributes methotrexate resistance proto-
  stage protozoan parasite Leishmania major                 zoan parasite Leishmania tarentolae. EMBO J 18: 2342â€“
  tetrahydrobiopterin. Science 292: 285â€“287.                          2351.
Dawson, , Gibellini, F., Sienkiewicz, N., Tulloch, L.B., Fyfe,   Lemley, C., Yan, S.F., Dole, V.S., Madhubala, R., Cunning-
  P.K., McLuskey, K., et al. (2006) Structure reactivity       ham, M.L., Beverley, S.M., et al. (1999) Leishmania
  Trypanosoma brucei pteridine reductase: inhibition           donovani LD1 locus gene ORFG encodes biopterin
  archetypal antifolate methotrexate. Mol Microbiol 61:               transporter (BT1). Mol Biochem Parasitol 104: 93â€“105.
  1457â€“1468.                                                       Li, Y., Wang, C.C. (2006) Changing roles aurora-B
Fukushima, T., Nixon, J.C. (1980) Analysis reduced             kinase life cycle stages Trypanosoma brucei.
  forms biopterin biological tissues fluids. Anal           Eukaryotic Cell 5: 1026â€“1035.
  Biochem 102: 176â€“188.                                            Lorenz, P., Maier, G., Baumgart, E., Erdmann, R., Furuya, T., Kessler, P., Jardim, , Schnaufer, , Crudder,          Clayton, C. (1998) Elongation clustering glyco-
  C., Parsons, M. (2002) Glucose toxic glycosome-           somes Trypanosoma brucei overexpressing glyco-
  deficient trypanosomes. Proc Natl Acad Sci USA 99:                  somal Pex11p. EMBO J 17: 3542â€“3555.
  14177â€“14182.                                                     Luba, J., Nare, B., Liang, P.H., Anderson, K.S., Beverley,
Gourley, D.G., Schuttelkopf, W., Leonard, G , Luba, J.,           S.M., Hardy, L.W. (1998) Leishmania major pteridine
  Hardy, L.W., Beverley, S.M., Hunter, W.N. (2001) Pte-           reductase 1 belongs short chain dehydrogenase
  ridine reductase mechanism correlates pterin metabolism             family: stereochemical kinetic evidence. Biochemistry
  drug resistance trypanosomatid parasites. Nat               37: 4093â€“4104.
  Struct Biol 8: 521â€“525.                                          Lux, H., Heise, N., Klenner, T., Hart, D., Opperdoes, F.R.
Hardy, L.W., Matthews, W., Nare, B., Beverley, S.M.               (2000) Ether-lipid (alkyl-phospholipid) metabolism   (1997) Biochemical genetic tests inhibitors Leish-       mechanism action ether-lipid analogues   mania pteridine pathways. Exp Parasitol 87: 157â€“169.                Leishmania. Mol Biochem Parasitol 111: 1â€“14.
Heise, N., Opperdoes, F.R. (1997) dihydroxyaceto-          Lye, L.F., Cunningham, M.L., Beverley, S.M. (2002)
  nephosphate pathway biosynthesis ether lipids             Characterization quinonoid-dihydropteridine reductase
  Leishmania mexicana promastigotes. Mol Biochem Para-                (QDPR) lower eukaryote Leishmania major. J Biol
  sitol 89: 61â€“72.                                                    Chem 277: 38245â€“38253.
Ivens, C., Peacock, C.S., Worthey, E , Murphy, L.,             Ma, D.Q., Beverley, S.M., Turco, S.J. (1996) Leishmania
  Aggarwal, G., Berriman, M., et al. (2005) genome             donovani possess NADPH-dependent alkylglycerol
  kinetoplastid parasite, Leishmania major. Science 309:          cleavage enzyme. Biochem Biophys Res Commun 227:
  436â€“442.                                                            885â€“889.
Jetton, N., Rothberg, K.G., Hubbard, J.G., Wise, J., Li, Y.,       Michels, P M., Bringaud, F., Herman, M., Hannaert,
  Ball, H.L., Ruben, L. (2009) cell cycle thera-         V. (2006) Metabolic functions glycosornes   peutic target Trypanosoma brucei: hesperadin                trypanosomatids. Biochim Biophys Acta 1763: 1463â€“1477.
  inhibits Aurora kinase-1 blocks mitotic progression       Mogi, M., Kinpara, K., Kondo, , Togari,  (1999)
  bloodstream forms. Mol Microbiol 72: 442â€“458.                       Involvement nitric oxide biopterin proinflammatory
Jockers-Scherubl, M.C., Schirmer, R.H., Krauth-Siegel,            cytokine-induced apoptotic cell death mouse osteoblas-
  R.L. (1989) Trypanothione reductase Trypanosoma                tic cell line MC3T3-E1. Biochem Pharmacol 58: 649â€“654.

Â© 2010 Blackwell Publishing  Molecular Microbiology, 77, 658â€“671
 670 N. Sienkiewicz, H. B. Ong  H. Fairlamb äŠ?

Moreira, W., Leblanc, E., Ouellette, M. (2009) role          Schlecker, T., Schmidt, , Dirdjaja, N., Voncken, F., Clayton,
  reduced pterins resistance reactive oxygen nitro-             C., Krauth-Siegel, R.L. (2005) Substrate specificity,
  gen intermediates protozoan parasite Leishmania.                 localization, essential role glutathione
  Free Radic Biol Med 46: 367â€“375.                                        peroxidase-type tryparedoxin peroxidases Trypanosoma
Moyersoen, J., Choe, J., Kumar, , Voncken, F.G.J., Hol,                 brucei. J Biol Chem 280: 14385â€“14394.
  W.G.J., Michels, P M. (2003) Characterization Try-           Schmidt, T.S., Alp, N.J. (2007) Mechanisms role
  panosoma brucei PEX14 role import gly-                tetrahydrobiopterin endothelial function vascular
  cosomal matrix proteins. Eur J Biochem 270: 2059â€“2067.                  disease. Clin Sci 113: 47â€“63.
Mpamhanga, C.P., Spinks, D., Tulloch, L.B., Shanks, E.J.,               Schormann, N., Pal, B., Senkovich, O., Carson, M., Howard,
  Robinson, D , Collie, T., et al. (2009) scaffold,               , Smith, C., et al. (2005) Crystal structure Trypano-
  binding modes: novel selective pteridine reduc-               soma cruzi pteridine reductase 2 complex sub-
  tase 1 Inhibitors derived fragment hits discovered              strate inhibitor. J Struct Biol 152: 64â€“75.
  virtual screening. J Med Chem 52: 4454â€“4465.                          Schuttelkopf, W., Hardy, L.W., Beverley, S.M., Hunter,
Nare, B., Luba, J., Hardy, L.W., Beverley, S.M. (1997)                W.N. (2005) Structures Leishmania major pteridine
  New approaches Leishmania chemotherapy: pteridine                    reductase complexes reveal active site features impor-
  reductase 1 (PTR1) target modulator antifolate              tant ligand binding guide inhibitor design. J Mol
  sensitivity. Parasitol 114: S101â€“S110.                                  Biol 352: 105â€“116.
Nare, B., Garraway, L , Vickers, T.J., Beverley, S.M.             Selvapandiyan, , Kumar, P., Morris, J.C., Salisbury, J.L.,
  (2009) PTR1-dependent synthesis tetrahydrobiopterin                  Wang, C.C., Nakhasi, H.L. (2007) Centrin1 required
  contributes oxidant susceptibility trypanosomatid             organelle segregation cytokinesis Trypanosoma
  protozoan parasite Leishmania major. Curr Genet 55: 287â€“                brucei. Mol Biol Cell 18: 3290â€“3301.
  299.                                                                  Shanks, E.J., Ong, H.B., Robinson, D , Thompson, S.,
Nichol, C , Lee, C.L., Edelstein, M.P., Chao, J.Y., Duch,           Sienkiewicz, N., Fairlamb, H., Frearson, J  (2010)
  D.S. (1983) Biosynthesis tetrahydrobiopterin novo              Development validation cytochrome c coupled
  salvage pathways adrenal-medulla extracts,                       assay pteridine reductase 1 dihydrofolate
  mammalian-cell cultures, rat-brain vivo. Proc Natl               reductase. Anal Biochem 396: 194â€“203.
  Acad Sci USA 80: 1546â€“1550.                                           Sheader, K., Vaughan, S., Minchin, J., Hughes, K., Gull, K.,
Olego-Fernandez, S., Vaughan, S., Shaw, M.K., Gull, K.,               Rudenko, G. (2005) Variant surface glycoprotein RNA
  Ginger, M.L. (2009) Cell morphogenesis Trypanosoma                   interference triggers precytokinesis cell cycle arrest   brucei requires paralogous, differentially expressed                African trypanosomes. Proc Natl Acad Sci USA 102: 8716â€“
  calpain-related proteins CAP5.5 CAP5.5V. Protist 160:               8721.
  576â€“590.                                                              Sienkiewicz, N., Jaroslawski, S., Wyllie, S., Fairlamb,
Opperdoes, F.R., Szikora, J.P. (2006) silico prediction            H. (2008) Chemical genetic validation dihydro-
  glycosomal enzymes Leishmania major                       folate reductase-thymidylate synthase drug target   trypanosomes. Mol Biochem Parasitol 147: 193â€“206.                       African trypanosomes. Mol Microbiol 69: 520â€“533.
Opperdoes, F.R., Baudhuin, P., Coppens, , Roe, C.,                 Smith, K., Opperdoes, F.R., Fairlamb, H. (1991) Sub-
  Edwards, S.W., Weijers, P.J., Misset, O. (1984) Puri-               cellular distribution trypanothione reductase blood-
  fication, morphometric analysis, characterization            stream procyclic forms Trypanosoma brucei. Mol
  glycosomes (microbodies) protozoan hemoflagellate                Biochem Parasitol 48: 109â€“112.
  Trypanosoma brucei. J Cell Biol 98: 1178â€“1184.                        Thony, B., Auerbach, G., Blau, N. (2000) Tetrahydrobiop-
Ouellette, M., Drummelsmith, J., El Fadili, , Kundig, C.,               terin biosynthesis, regeneration functions. Biochem J
  Richard, D., Roy, G. (2002) Pterin transport                    347: 1â€“16.
  metabolism Leishmania related trypanosomatid                   Tulloch, L.B., Martini, V.P., Iulek, J., Huggan, J.K., Lee, J.H.,
  parasites. Int J Parasitol 32: 385â€“398.                                 Gibson, C.L., et al. (2010) Structure-based design pte-
Ozkor, M , Quyyumi,  (2008) Tetrahydrobiopterin.                ridine reductase inhibitors targeting African sleeping sick-
  Curr Hypertens Rep 10: 58â€“64.                                